Detalhe da pesquisa
1.
Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications.
Semin Cancer Biol
; 83: 152-165, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32858230
2.
Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy.
J Transl Med
; 21(1): 235, 2023 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37004094
3.
Expression profile of KIR3DS1/KIR3DL1 receptors in association with immunological responses in TB, HIV and HIV/TB infected patients.
Microb Pathog
; 180: 106145, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37169313
4.
Efficacy of oral and topical antioxidants in the prevention and management of oral mucositis in head and neck cancer patients: a systematic review and meta-analyses.
Support Care Cancer
; 30(11): 8689-8703, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35680672
5.
The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
Tumour Biol
; 43(1): 177-196, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34420993
6.
Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy.
J Transl Med
; 18(1): 140, 2020 03 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32220256
7.
Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance.
Mol Cancer
; 18(1): 55, 2019 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30925923
8.
Vivax malaria and chloroquine resistance: a neglected disease as an emerging threat.
Malar J
; 14: 146, 2015 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25889875
9.
Tumour necrosis factor, interleukin-6 and interleukin-10 are possibly involved in Plasmodium vivax-associated thrombocytopaenia in southern Pakistani population.
Malar J
; 13: 323, 2014 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25128199
10.
The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers.
Biomed Pharmacother
; 171: 116095, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38183744
11.
Severe Plasmodium vivax malaria in Pakistan.
Emerg Infect Dis
; 19(11): 1851-4, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24188313
12.
Prevalence of drug resistance associated mutations in Plasmodium vivax against sulphadoxine-pyrimethamine in southern Pakistan.
Malar J
; 12: 261, 2013 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-23890361
13.
Genetic diversity of Plasmodium vivax clinical isolates from southern Pakistan using pvcsp and pvmsp1 genetic markers.
Malar J
; 12: 16, 2013 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23311628
14.
In silico targeting of colony-stimulating factor-1 receptor: delineating immunotherapy in cancer.
Explor Target Antitumor Ther
; 4(4): 727-742, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37711590
15.
Multiple myeloma and its rare paraneoplastic manifestations simmering under the surface.
Pathol Res Pract
; 248: 154689, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37478520
16.
Role of circulating-tumor DNA in the early-stage non-small cell lung carcinoma as a predictive biomarker.
Pathol Res Pract
; 245: 154455, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37054576
17.
Corrigendum: Curcumin-mediated degradation of S-phase kinase protein 2 induces cytotoxic effects in human papillomavirus-positive and negative squamous carcinoma cells.
Front Oncol
; 13: 1292898, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37841444
18.
Design and Evaluation of Hydrophobic Ion Paired Insulin Loaded Self Micro-Emulsifying Drug Delivery System for Oral Delivery.
Pharmaceutics
; 15(7)2023 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37514159
19.
The molecular mechanisms of apoptosis accompanied with the epigenetic regulation of the NY-ESO-1 antigen in non-small lung cancer cells treated with decitabine (5-aza-CdR).
Eur J Pharmacol
; 945: 175612, 2023 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36822455
20.
Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression.
Front Immunol
; 14: 1157100, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37256148